Biopep Solutions Inc.
200-13071 Vanier Place
Member Sector: Biopharmaceuticals
Biopep Solutions Inc. is a privately owned, development-stage biotechnology company dedicated to the discovery and development of innovative therapeutic products for the treatment of cancers and other diseases. We are pioneering the development of biopharmaceuticals that work through a multivalent mechanism of cancer inhibition with prostate cancer being our first indication. Our lead candidate drug, BPS-001, is a heterogeneous biologics that treats prostate cancer by non-toxically and simultaneously targeting multiple cancer causing pathways.
Preliminary pre-clinical pharmacological studies have been successfully completed and demonstrate our drug’s efficacy and safety. We anticipate earning approval of an Investigational New Drug Application (IND) from the FDA, and a Clinical Trial Application (CTA) from Health Canada to proceed with Phase 1/2 clinical testing.
Biopep Solutions is currently seeking sources of financing sufficient to fund upcoming milestones including gaining regulatory approval to commence clinical trials in cancer patients. To date, the company has been funded by private investors and government grants. Investments in Biopep Solutions are RRSP eligible and qualify for a 30% BC Tax Credit. Interested investors may contact us directly for details.